BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 31678386)

  • 1. Localized controlled release of bevacizumab and doxorubicin by thermo-sensitive hydrogel for normalization of tumor vasculature and to enhance the efficacy of chemotherapy.
    Darge HF; Andrgie AT; Hanurry EY; Birhan YS; Mekonnen TW; Chou HY; Hsu WH; Lai JY; Lin SY; Tsai HC
    Int J Pharm; 2019 Dec; 572():118799. PubMed ID: 31678386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulation of Thermo-responsive Gel in pH-sensitive Polymersomes as Dual-Responsive Smart carriers for Controlled Release of Doxorubicin.
    Oroojalian F; Babaei M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M
    J Control Release; 2018 Oct; 288():45-61. PubMed ID: 30171978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of corneal neovascularization by subconjunctival injection of avastin® loaded thermosensitive hydrogels in rabbit model.
    Xu X; Yu J; Shi H; Zhang J; Li X
    Int J Pharm; 2018 Dec; 552(1-2):164-170. PubMed ID: 30217769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of doxorubicin and (131)I by thermosensitive micellar-hydrogel for enhanced in situ synergetic chemoradiotherapy.
    Huang P; Zhang Y; Wang W; Zhou J; Sun Y; Liu J; Kong D; Liu J; Dong A
    J Control Release; 2015 Dec; 220(Pt A):456-464. PubMed ID: 26562684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency.
    Xu S; Wang W; Li X; Liu J; Dong A; Deng L
    Eur J Pharm Sci; 2014 Oct; 62():267-73. PubMed ID: 24931190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.
    Cao D; Zhang X; Akabar MD; Luo Y; Wu H; Ke X; Ci T
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):181-191. PubMed ID: 30686051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermo-sensitive polypeptide hydrogel for locally sequential delivery of two-pronged antitumor drugs.
    Wei L; Chen J; Zhao S; Ding J; Chen X
    Acta Biomater; 2017 Aug; 58():44-53. PubMed ID: 28576715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermosensitive porphyrin-incorporated hydrogel with four-arm PEG-PCL copolymer (II): doxorubicin loaded hydrogel as a dual fluorescent drug delivery system for simultaneous imaging tracking in vivo.
    Dong X; Chen H; Qin J; Wei C; Liang J; Liu T; Kong D; Lv F
    Drug Deliv; 2017 Nov; 24(1):641-650. PubMed ID: 28282993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermosensitive poly-(d,l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d,l-lactide-co-glycolide) hydrogels for multi-drug delivery.
    Cho H; Kwon GS
    J Drug Target; 2014 Aug; 22(7):669-77. PubMed ID: 24964052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy.
    Gao D; Lo PC
    J Control Release; 2018 Jul; 282():46-61. PubMed ID: 29673646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel.
    Huang Z; Xiao H; Lu X; Yan W; Ji Z
    Int J Nanomedicine; 2018; 13():7623-7631. PubMed ID: 30538447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release.
    Xu M; Zhang CY; Wu J; Zhou H; Bai R; Shen Z; Deng F; Liu Y; Liu J
    ACS Appl Mater Interfaces; 2019 Feb; 11(6):5701-5713. PubMed ID: 30644711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The characterisitics of temperature/pH sensitive block copolymer micelles in vitro].
    Jia L; Qiao MX; Hu HY; Zhao XL; Chen DW
    Yao Xue Xue Bao; 2011 Jul; 46(7):839-44. PubMed ID: 22010355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor.
    Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X
    Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxime linkage: a robust tool for the design of pH-sensitive polymeric drug carriers.
    Jin Y; Song L; Su Y; Zhu L; Pang Y; Qiu F; Tong G; Yan D; Zhu B; Zhu X
    Biomacromolecules; 2011 Oct; 12(10):3460-8. PubMed ID: 21863891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery.
    Shuai X; Ai H; Nasongkla N; Kim S; Gao J
    J Control Release; 2004 Aug; 98(3):415-26. PubMed ID: 15312997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
    Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X
    Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diels-Alder hydrogels with enhanced stability: First step toward controlled release of bevacizumab.
    Kirchhof S; Gregoritza M; Messmann V; Hammer N; Goepferich AM; Brandl FP
    Eur J Pharm Biopharm; 2015 Oct; 96():217-25. PubMed ID: 26253504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.